Zichron-Yaakov, Israel

Yaacov Rozenblum

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Carmel—haifa University Economic Corp Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yaacov Rozenblum. Retrieved from https://idiyas.com/inventor/yaacov-rozenblum

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yaacov Rozenblum

Introduction

Yaacov Rozenblum is an accomplished inventor based in Zikhron Ya'akov, Israel. He has made significant contributions to the field of mental health through his innovative approaches to treatment. His work focuses on methods for treating depression and major depressive disorder, showcasing his commitment to improving the lives of those affected by these conditions.

Latest Patents

Rozenblum holds a patent for "Methods for treating depression and major depressive disorder." This patent outlines methods for treating depression in subjects, which include decreasing the dose of ketamine administered. The innovative approach involves the use of a CaMKII inhibitor, providing a new avenue for treatment options.

Career Highlights

Yaacov Rozenblum is associated with Carmel—Haifa University Economic Corp Ltd., where he continues to develop and refine his innovative ideas. His work has garnered attention for its potential impact on mental health treatment, making him a notable figure in the field.

Collaborations

Rozenblum collaborates with talented individuals such as Elham Taha and Chinnakkaruppan Adaikkan. These partnerships enhance the research and development of his innovative methods, contributing to a collaborative environment that fosters creativity and progress.

Conclusion

Yaacov Rozenblum's contributions to the field of mental health through his innovative patent demonstrate his dedication to improving treatment methods for depression. His work continues to inspire and pave the way for future advancements in this critical area of healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…